166 related articles for article (PubMed ID: 15578072)
1. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma.
Jung SM; Kuo TT
Mod Pathol; 2005 Jun; 18(6):788-94. PubMed ID: 15578072
[TBL] [Abstract][Full Text] [Related]
2. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
Hoang MP; Amirkhan RH
Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
[TBL] [Abstract][Full Text] [Related]
3. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
[TBL] [Abstract][Full Text] [Related]
4. Spinal Versus Intracranial Meningioma: Aberrant Expression of CD10 and Inhibin with Relation to Clinicopathological Features and Prognosis.
Foda AAM; Rafi S; Ikram N; Alam MS; Ayesha S
Pathol Oncol Res; 2020 Apr; 26(2):1313-1318. PubMed ID: 31372897
[TBL] [Abstract][Full Text] [Related]
5. Sporadic hemangioblastoma of the kidney with PAX2 and focal CD10 expression: report of a case.
Jiang JG; Rao Q; Xia QY; Tu P; Lu ZF; Shen Q; Zhang RS; Yu B; Zhou XJ; Shi SS; Shi QL
Int J Clin Exp Pathol; 2013; 6(9):1953-6. PubMed ID: 24040464
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic study of primary renal hemangioblastoma].
Zhang X; Wang X; Wang J; Shen Q; Xia Q; Shi S; Lu Z; Ma H; Zhang R; He Y; Yu B; Zhou X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2015 Jun; 44(6):377-81. PubMed ID: 26704830
[TBL] [Abstract][Full Text] [Related]
7. Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas.
Brown DF; Dababo MA; Hladik CL; Eagan KP; White CL; Rushing EJ
Mod Pathol; 1998 Jan; 11(1):55-9. PubMed ID: 9556423
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
[TBL] [Abstract][Full Text] [Related]
9. Sporadic haemangioblastoma of the kidney with rhabdoid features and focal CD10 expression: report of a case and literature review.
Yin WH; Li J; Chan JK
Diagn Pathol; 2012 Apr; 7():39. PubMed ID: 22497861
[TBL] [Abstract][Full Text] [Related]
10. Metastatic renal cell carcinoma to hemangioblastoma in von Hippel-Lindau disease.
Polydorides AD; Rosenblum MK; Edgar MA
Arch Pathol Lab Med; 2007 Apr; 131(4):641-5. PubMed ID: 17425399
[TBL] [Abstract][Full Text] [Related]
11. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
[TBL] [Abstract][Full Text] [Related]
12. CD10 is expressed in a subset of chromophobe renal cell carcinomas.
Martignoni G; Pea M; Brunelli M; Chilosi M; Zamó A; Bertaso M; Cossu-Rocca P; Eble JN; Mikuz G; Puppa G; Badoual C; Ficarra V; Novella G; Bonetti F
Mod Pathol; 2004 Dec; 17(12):1455-63. PubMed ID: 15286660
[TBL] [Abstract][Full Text] [Related]
13. Metastatic Renal Cell Carcinoma to the Brain: A Contemporary Clinicopathologic Analysis With Comparison of Immunohistochemical Profiles to Selected Primary Brain Tumors With Clear Cell Features.
Zheng W; Goodman AL; Velázquez Vega JE; Yin F; Fung KM; Osunkoya AO
Appl Immunohistochem Mol Morphol; 2020; 28(5):395-402. PubMed ID: 30882396
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic characteristics of sporadic renal hemangioblastoma].
Guo J; Li L; Zhao LH; Li Y; Wang LS; Xiao L; Zhang RY
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):679-82. PubMed ID: 24433731
[TBL] [Abstract][Full Text] [Related]
15. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration.
Yang B; Ali SZ; Rosenthal DL
Diagn Cytopathol; 2002 Sep; 27(3):149-52. PubMed ID: 12203861
[TBL] [Abstract][Full Text] [Related]
16. Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma.
Prayson RA; Chamberlain WA; Angelov L
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):422-8. PubMed ID: 20453815
[TBL] [Abstract][Full Text] [Related]
17. GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.
North PE; Mizeracki A; Mihm MC; Mrak RE
Clin Neuropathol; 2000; 19(3):131-7. PubMed ID: 14606586
[TBL] [Abstract][Full Text] [Related]
18. PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.
Zhao M; Williamson SR; Yu J; Xia W; Li C; Zheng J; Zhu Y; Sun K; Wang Z; Cheng L
Hum Pathol; 2013 Oct; 44(10):2247-55. PubMed ID: 23849894
[TBL] [Abstract][Full Text] [Related]
19. Clear cell renal cell carcinoma with hemangioblastoma-like features: A recently described pattern with unusual immunohistochemical profile.
Sancheti S; Menon S; Mukherjee S; Arun I
Indian J Pathol Microbiol; 2015; 58(3):354-5. PubMed ID: 26275263
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
